IMTXW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW
Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.
Immatics (NASDAQ:IMTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends, valuation and community ranking.
Immatics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
In the previous week, Immatics and Immatics both had 1 articles in the media. Immatics' average media sentiment score of 1.89 equaled 180 Life Sciences'average media sentiment score.
Summary
Immatics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.
Get Immatics News Delivered to You Automatically
Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IMTXW vs. The Competition
Immatics Competitors List
Related Companies and Tools
